# The association of prescriber prominence in a shared-patient physician network with their patients receipt of and transitions between risky drug combinations

**Authors:** A. James O’Malley, Ellen Meara, Nancy E. Morden, Erika L. Moen, Xin Ran

PMC · DOI: 10.1007/s41109-025-00721-y · Applied Network Science · 2025-07-21

## TL;DR

This study explores how a doctor's position in a shared-patient network affects their patients' use of risky drug combinations.

## Contribution

The study introduces a novel approach to analyzing prescribing behavior through shared-patient physician networks.

## Key findings

- Physicians with higher closeness centrality are less likely to prescribe risky drug combinations.
- Psychiatrists are more likely to prescribe risky drug combinations than primary care physicians.
- Patients of psychiatrists are less likely to discontinue overlapping three-drug prescriptions.

## Abstract

We are generally interested in the association between a prescribing physician’s position in a physician shared-patient network and their patients’ receipt of risky drug combinations. An informal physician network (not restricted to a hospital or a health system) of physicians based in Ohio was constructed based on overlapping care of patients between physicians reflected in face-to-face visits in Fee-for-service Medicare claims for Ohio-residing beneficiaries. Separately, Medicare prescription drug events for beneficiaries receiving opioids, benzodiazepines, or non-benzodiazepine sedative hypnotics (sedative hypnotics) prescribed by these physicians in 2014 were used to map patients’ drug status with respect to these three classes. We assigned patient prescription receipt to time-varying drug states and linked each drug state transition to a “responsible” prescribing physician. Outcomes of interest include transitions across drug states, particularly those resulting in combinations of increased risk (e.g., a benzodiazepine or sedative hypnotic with an opioid), and patients’ time to discontinuation of overlapping prescriptions of an opioid, benzodiazepine, and a sedative hypnotic while the key predictors of these transitions reflected characteristics of a prescriber’s physician network position and physician speciality. We found that among beneficiaries receiving none of the three risky drug groups, patients seeing physicians with higher closeness centrality (shorter average path lengths to other physicians through the network) were less likely to transition to two or three risky drugs; and they were more likely to discontinue overlapping prescriptions of an opioid, benzodiazepine, and sedative hypnotic. Compared to PCPs, psychiatrists appeared more likely to prescribe risky drug combinations, and their patients were less likely to discontinue overlapping three-drug prescriptions. This work demonstrates that characterizing physicians’ prescribing behavior in relation to their position in shared-patient networks may reveal strategies for optimizing network-based interventions to improve prescribing quality.

The online version contains supplementary material available at 10.1007/s41109-025-00721-y.

## Linked entities

- **Chemicals:** opioids (PubChem CID 126961754)

## Full-text entities

- **Chemicals:** benzodiazepine (MESH:D001569)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12279612/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12279612/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12279612/full.md

---
Source: https://tomesphere.com/paper/PMC12279612